JOSEPH URBANSKI: Open Payments
NPI 1497116453 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$720 in 44 payments from 11 companies in 2025. Trend: 2023 $204 · 2024 $389 · 2025 $720
Food & beverage: $720
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 28 | $385 |
| Novartis Pharmaceuticals Corporation | 3 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $66 |
| Boston Scientific Corporation | 2 | $46 |
| SCPHARMACEUTICALS INC. | 2 | $41 |
| Actelion Pharmaceuticals US, Inc. | 1 | $32 |
| Amgen Inc. | 1 | $18 |
| Impulse Dynamics (USA) Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $17 |
| Medtronic, Inc. | 1 | $17 |
Products named: CAMZYOS, LEQVIO, Kerendia, CDS - MCT/CEM Monitoring, FUROSCIX, UPTRAVI, REPATHA, Optimizer.
Industry payments across MI — which companies pay providers there.
